Source 1primary paper2025MED
Toolkit/synthetic intramembrane proteolysis receptor
synthetic intramembrane proteolysis receptor
Also known as: SNIPR
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
here we adapt a receptor architecture called the synthetic intramembrane proteolysis receptor (SNIPR) for activation by soluble ligands
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
Objective: Engineer a modular SNIPR-based receptor platform that senses soluble ligands and activates customized cellular functions for therapeutic control and synthetic cell-cell communication.
Why it works: The abstract states that the adapted SNIPR platform can be activated by natural and synthetic soluble factors through an endocytic, pH-dependent cleavage mechanism, enabling soluble-cue sensing to drive bespoke cellular outputs.
endocytic activationpH-dependent cleavagereceptor architecture adaptationcell engineering
Objective: Characterize small molecule- and cell contact-inducible systems for controlling gene expression and differentiation in mouse embryonic stem cells.
Why it works: The paper frames mESCs as a genetically tractable pluripotent model and tests multiple inducible systems to determine whether they can reliably control arbitrary payload expression and differentiation outputs in that context.
small molecule-inducible transcriptional controlcell contact-inducible transcriptional controlinducible control of differentiationsystem characterization in mESCscomparative testing across model differentiations
Stages
- 1.Characterization of inducible systems for payload expression in mESCs(functional_characterization)
This stage establishes whether the tested inducible systems function for gene expression control in mESCs.
Selection: Whether small molecule- and cell contact-inducible systems can control expression of arbitrary genetic payloads reliably and efficiently in mESCs
- 2.Comparison across model differentiations(secondary_characterization)
This stage examines whether system behavior changes across differentiation contexts rather than only in undifferentiated mESCs.
Selection: How the inducible systems function differently across model differentiations
- 3.Direct neuronal differentiation application(confirmatory_validation)
This stage tests whether inducible control of expression is sufficient to produce a concrete developmental application outcome.
Selection: Whether the inducible systems can drive direct differentiation of mESCs into neurons
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Mechanisms
Degradationendocytic activationintramembrane proteolysisph-dependent cleavagePhotocleavageTechniques
No technique tags yet.
Target processes
degradationInput: Chemical
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The SNIPR platform was applied to engineer fully synthetic signalling networks between cells that are orthogonal to natural signalling pathways.
The authors adapted the SNIPR receptor architecture for activation by soluble ligands.
The soluble-ligand-responsive SNIPR platform is activated through an endocytic, pH-dependent cleavage mechanism.
The SNIPR platform can be activated by both natural and synthetic soluble factors with low baseline activity and high fold activation.
The receptor platform localized CAR T-cell activity to solid tumours expressing soluble disease-associated factors, aiming to bypass on-target off-tumour toxicity in bystander organs.
Approval Evidence
2 sources5 linked approval claimsfirst-pass slugs snipr, synthetic-intramembrane-proteolysis-receptor
here we adapt a receptor architecture called the synthetic intramembrane proteolysis receptor (SNIPR) for activation by soluble ligands
Source:
Full text indicates the study adapts three small-molecule-inducible transcription factor systems in mESCs based on 4-hydroxytamoxifen/ERT2, abscisic acid ABI/PYL, and grazoprevir/NS3, and two juxtacrine systems based on synNotch and SNIPR with an ALFA-tag ligand.
Source:
applicationsupports
The SNIPR platform was applied to engineer fully synthetic signalling networks between cells that are orthogonal to natural signalling pathways.
Source:
engineering advancesupports
The authors adapted the SNIPR receptor architecture for activation by soluble ligands.
Source:
mechanismsupports
The soluble-ligand-responsive SNIPR platform is activated through an endocytic, pH-dependent cleavage mechanism.
Source:
performancesupports
The SNIPR platform can be activated by both natural and synthetic soluble factors with low baseline activity and high fold activation.
Source:
therapeutic applicationsupports
The receptor platform localized CAR T-cell activity to solid tumours expressing soluble disease-associated factors, aiming to bypass on-target off-tumour toxicity in bystander organs.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.